{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-056983","form_type":"8-K","ticker":"CUE","cik":"0001645460","company_name":"Cue Biopharma, Inc.","filed_at":"2026-02-18T23:59:59+00:00","discovered_at":"2026-05-14T18:02:35.733769+00:00","generated_at":"2026-05-16T02:05:23.942978+00:00","sec_items":["8.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"Cue Biopharma sets 2026 annual meeting for April 13; shareholder deadlines on Feb 28.","bullets":["Annual meeting date: April 13, 2026.","Shareholder proposals under Rule 14a-8 must be received by February 28, 2026.","Director nominations and other business also due by February 28, 2026 per Bylaws and Rule 14a-19.","Proxies may exercise discretionary voting on late proposals."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-056983","json":"https://secwatch.observer/filing/0001193125-26-056983.json","markdown":"https://secwatch.observer/filing/0001193125-26-056983.md","text":"https://secwatch.observer/filing/0001193125-26-056983.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1645460/000119312526056983/0001193125-26-056983-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1645460/000119312526056983/cue-20260218.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T02:05:23.942978+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}